Bripca 10 mg Solution 100 ml

Bripca 10 mg Solution 1 is used for treating partial-onset seizures (seizures involving only one part of the brain) in people with epilepsy (fits) in patients one month of age and older. Partial-onset seizures are characterized by abnormal electrical activity in only one brain hemisphere. Common symptoms are involuntary muscle contractions, followed by relaxation on one side of the body, uncontrolled head or eye movements, rapid heart rate, and a tingling sensation on the skin.

Bripca 10 mg Solution 1 contains '‘Brivaracetam' that reduces the electrical impulses and subsequent firing of the nerve impulses that cause fits. Thus, Bripca 10 mg Solution 1 decreases the brain's excessive and abnormal nerve activity, thereby controlling seizures.

Bripca 10 mg Solution 1 should be used as prescribed by the doctor. In some cases, you may experience certain common side effects such as somnolence (excess sleepiness), dizziness, fatigue (feeling overtired), nausea and vomiting. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

To treat your condition effectually, continue taking Bripca 10 mg Solution 1 for as long as your doctor has prescribed. Bripca 10 mg Solution 1 should be gradually withdrawn, so please do not stop taking Bripca 10 mg Solution 1 without consulting your doctor. Before taking the Bripca 10 mg Solution 1, let your doctor know about all your medical conditions, sensitivities, and medications you are using. Inform your doctor if you are pregnant or planning to become pregnant. You should not breastfeed unless the doctor advises. Consult your doctor immediately if you experience suicidal tendencies. It is recommended not to drive or operate machinery as Bripca 10 mg Solution 1 may cause tiredness and fatigue. It is recommended not to take alcoholic beverages while on Brivaracetam therapy.

Bripca 10 mg Solution 1 belongs to a group of medicines called anticonvulsants or anti-epileptics used to treat partial-onset seizures in people with epilepsy (fits). Bripca 10 mg Solution 1 consists of Brivaracetam, which works by reducing the electrical impulses and subsequent firing of the nerve impulses that cause fits. Bripca 10 mg Solution 1 decreases the excessive and abnormal nerve activity in the brain, thereby helping in controlling seizures.

Shake the bottle well before each use. Take the prescribed dose by mouth using the measuring cup, dosing syringe, or dropper.

• Drowsiness
• Tiredness
• Fatigue
• Asthenia (weakness)
• Malaise (General discomfort)
• Hypersomnia (Excessive sleepiness)
• Sedation
• Lethargy (a lack of energy)
• Dizziness
• Vertigo (Spinning sensation)
• Balance disorder
• Ataxia (Impaired coordination)
• Nystagmus (Involuntary eye movement)
• Gait disturbance (a manner of walking or moving on foot)
• Abnormal coordination

Before taking the Bripca 10 mg Solution 1, inform your doctor about all your medical conditions, allergic conditions, and all medications you are using. Inform your doctor if you are pregnant or planning to become pregnant. If you become pregnant while taking Bripca 10 mg Solution 1, call your doctor. You should not breastfeed unless the doctor advises. Consult your doctor immediately if you experience suicidal tendencies or feel it worsens your condition. It is recommended not to drive or operate machinery as Bripca 10 mg Solution 1 may cause tiredness and fatigue. It is recommended not to take alcoholic beverages while on Brivaracetam therapy. Do not stop Bripca 10 mg Solution 1 without first talking to a healthcare provider. Stopping the usage of Bripca 10 mg Solution 1 suddenly can cause serious problems. Sometimes, it may lead to seizures that will not stop (status epilepticus).

Drug-Drug Interactions: Bripca 10 mg Solution 1 may interact with other anticonvulsants (e.g. carbamazepine, phenytoin, levetiracetam), antibiotics (e.g. rifampin), opioid analgesics (e.g. buprenorphine, propoxyphene), anaesthetics (e.g. ketamine/esketamine) and medications are used to treat narcolepsy (e.g. sodium oxybate)

Drug-Food Interactions: Avoid alcohol consumption while taking Bripca 10 mg Solution 1 as it might cause increased dizziness and sleepiness.

Drug-Disease Interactions: Bripca 10 mg Solution 1 may interact with disease various conditions, including liver/kidney impairment, suicidal tendency or ideation and lactose intolerance.

• CARBAMAZEPINE
• PHENYTOIN
• LEVETIRACETAM
• RIFAMPICIN
• BUPRENORPHINE
• PROPOXYPHENE
• KETAMINE
• ESKETAMINE
• SODIUM OXYBATE

• ​A ketogenic diet (low in carbohydrates and high in fats) is recommended for children with epilepsy. This diet helps utilise fat instead of glucose for energy generation.
• The Atkins diet (high fat and controlled carbohydrates) is recommended for adolescents and adults.
• Exercising regularly helps maintain weight and improve overall health. 
• Rest well, and get plenty of sleep.
• Avoid smoking and alcohol consumption.
• Meditation and yoga can help lower stress, decrease pain sensitivity and improve coping skills.
• Have a seizure response plan, and help those around you know what to do.
• Prepare your living area; small changes may reduce the risk of physical injury during a seizure.
• Understand what triggers seizures are and try reducing or avoiding them.
• Please pay attention to overall health, as it can help reduce seizure activity.
• Install an alarm or emergency device to get assistance during a seizure attack.

• Pay close attention to any changes in mood, behaviour, thoughts, or feelings, especially if they are sudden.
• Maintain all scheduled follow-up appointments with your healthcare practitioner.

Partial-onset seizures: Partial-onset seizures are characterized by abnormal electrical activity in only one brain hemisphere. Common symptoms are involuntary muscle contractions, followed by relaxation on one side of the body, Hallucinations, uncontrolled head or eye movements, rapid heart rate, and a tingling sensation on the skin. The symptoms vary in each patient depending on the part of the brain affected.